"Are you experiencing: premature aging? Loose, thin sagging skin? Wrinkles? Increased body fat? Decreased muscle mass? A decrease in strength and endurance? Joint inflammation? A decrease in flexibility and mobility? Elevated cholesterol? A disturbance in sleep and sexual function? Mild depression?

      If you answered "yes" to any or all of these questions, and you are interested in participating in an approved study of the affects of growth hormone replacement on aging, read the following information and click on Contact US to be considered for the study.

Origin of HGH Research

      In 1990, the publication of Dr. Daniel Rudman's landmark study in The New England Journal of Medicine (Vol.323), produced an intense interest by medical specialists in the use of recombinant growth hormone (rGH) to reverse some of the negative effects of aging. It was clear from the results of his study that use of rGH increased health and vitality during aging to the extent physicians couldn't ignore its benefits. Even though this protocol had received widespread recognition, it's approval by the FDA has been held up on the grounds of insufficient empirical testing and quantitative results. To this day, FDA approval and the use of growth hormone replacement is restricted. None the less, physicians do have the privilege of using whatever means appropriate and consistent with the goal of clinical practice to act in the patients best interest. The regular use of rGH to sustain health and vitality in aging patients has grown, and it is now the opinion of some, that it has become a standard of care. This has created the unusual situation of labeling the use of rGH for aging as acceptable by standard consensus, based on empirical rather than evidenced based medicine.

      Presently, pharmaceutical companies manufacturing growth hormones are enjoying significant profits from controlled sales without having had to comply with regulatory guidelines and make the necessary economic investments for research and development. Since there is a lack of sufficient research results consistent with the submission of data on safety and efficacy, it seems physicians choosing to use rGH replacement therapy should recognize they have an ethical and legal responsibility to inform the patient that treatment is off-label and should be considered investigational.